About Magellan Diagnostics
Magellan Diagnostics is a company based in Billerica (United States) founded in 1968 was acquired by Meridian Bioscience in March 2016. Magellan Diagnostics has raised $34 million across 3 funding rounds from investors including Meridian Bioscience, NIH and Abingworth. Magellan Diagnostics offers products and services including LeadCare II, LeadCare Plus, LeadCare Ultra, and Analytical Services. Magellan Diagnostics operates in a competitive market with competitors including Baseline Health, Oligoscan, Beaufort Bar and ToxTest, among others.
- Headquarter Billerica, United States
- SectorsHealthcare
- Website magellandx.com
- Social LinkedIn X
- Acquired by Meridian Bioscience (Mar 2016)
- Legal Name Meridian Bioscience, Inc.
- Total Equity Funding$34 M (USD)
in 3 rounds
- Latest Funding Round$16 M (USD), Debt – Conventional
Nov 29, 2006
- InvestorsMeridian Bioscience
& 9 more
- Acquired byMeridian Bioscience
(Mar 24, 2016)
Products & Services of Magellan Diagnostics
Magellan Diagnostics offers a comprehensive portfolio of products and services, including LeadCare II, LeadCare Plus, LeadCare Ultra, and Analytical Services.
CLIA-waived device for quick lead exposure detection in practices.
Solution for labs with smaller testing volumes and control features.
High-throughput system for convenient lead testing in high-volume settings.
Support for lead analysis and reporting to aid health risk management.
Funding Insights of Magellan Diagnostics
Magellan Diagnostics has successfully raised a total of $34M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $16 million completed in November 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.0M
- Total Rounds 3
- Last Round Debt – Conventional — $16.0M
- Investors Count 9
All 3 funding rounds of Magellan Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| 29 Nov 2006 | $34.0M | Series C | – | – | |
| 29 Nov 2006 | $16.0M | Debt – Conventional | – | – | |
| 21 Mar 2005 | – | Grant | – | – |
10 investors in total: 10 institutional.
Investors in Magellan Diagnostics
Magellan Diagnostics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and Abingworth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
- | – | kblvc.com | - | |
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | – | ampersandcapital.com | Boston, United States | |
A private investment firm focused on acquiring operating companies. | 1991 | necapitalpartners.com | Newton, United States | |
PE firm investing in Europe and the US | – | nmtcapital.com | Norwell, United States | |
BlueHub Capital is focused on community development financing for low-income areas. | – | bluehubcapital.org | Boston, United States | |
Investment advisory services are provided to financial clients. | 1986 | teklacap.com | Boston, United States | |
Financial services are provided by NewStar Financial in Boston. | 2004 | newstarfin.com | Boston, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Molecular diagnostic device and kits | 1976 | meridianbioscience.com | Ohio, United States |
Investor details for Magellan Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Magellan Diagnostics
4 dated milestones of Magellan Diagnostics across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Magellan Diagnostics is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Conventional, of $16.0M.
- Exit Acquired by Meridian Bioscience.
Competitors of Magellan Diagnostics
Magellan Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Baseline Health, Oligoscan, Beaufort Bar and ToxTest, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| getbaselinehealth.com | 2018 | San Francisco, United States | – | – | Develops test kits for diagnosing body toxins to promote health monitoring. | |
| oligoscan.com | 2010 | France | – | – | Develops innovative diagnostic devices for screening physiological imbalances. | |
| beaufort-bar.com | 2012 | Burlington, United States | – | – | Provides diagnostic tests for detecting lead poisoning to ensure public health safety. | |
| tox-test.de | 2011 | Esslingen Am Neckar, Germany | – | – | Offers DIY urine tests for detecting 11 heavy metals in the body. |
Detailed competitors of Magellan Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magellan Diagnostics
Complete news archive for Magellan Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Magellan Diagnostics
10 companies that operate in the same segment as Magellan Diagnostics (Toxicology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | – | – | |
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | – | – | |
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 | |
Non-invasive drug testing technology is developed using fingerprints. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 25.71 M | – | – | |
Provides toxicology, chemistry, and consultancy services for agrochemical industries. | 2020 | Vapi, Gujarat, India | – | – | – | |
Instruments for rapid human DNA identification are developed. | 2006 | Pleasanton, California, United States | USD 92.06 M | USD 22.5 B | 78 | |
Oral therapies for snake bite treatment are developed. | 2015 | Corte Madera, California, United States | USD 16.48 M | – | – | |
Quantitative urine drug testing is provided for patient monitoring. | 2011 | San Diego, California, United States | – | – | 358 | |
Real-time trace gas analysis solutions are delivered using SIFT-MS technology. | 2002 | Christchurch, New Zealand | USD 11.9 M | USD 23.52 M | – | |
Fentanyl test strips are supplied for harm reduction efforts. | 2005 | Los Angeles, California, United States | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Magellan Diagnostics
Magellan Diagnostics was founded in 1968 and raised its 1st funding round 37 years after it was founded.
Magellan Diagnostics is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.
Magellan Diagnostics is a funded company, having raised a total of $34M across 3 funding rounds to date.
Magellan Diagnostics develops point-of-care diagnostic platforms for heavy metal toxicity. The company was formerly known as ESA, Inc. and was founded by four PhD graduates from the Massachusetts Institute of Technology. It has three microfluidics-based platforms for lead testing at the point-of-care. The bench top analyzer for the measurement of lead in blood is based on Anodic Stripping Voltammetry (ASV). In addition, it also provides heavy metal toxicity testing services via its reference laboratory.
Magellan Diagnostics's top competitors include Baseline Health, Oligoscan and Beaufort Bar.
Magellan Diagnostics offers LeadCare II, LeadCare Plus, LeadCare Ultra, and Analytical Services.
Magellan Diagnostics has 10 investors. Key investors include Meridian Bioscience, NIH, Abingworth, Tekla Capital Management, and NewStar Financial.
Magellan Diagnostics operates through Meridian Bioscience, Inc..
Yes. Magellan Diagnostics was acquired by Meridian Bioscience in March 2016.